Ma, Xiuquan

Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment

Nguyen, E. V., Pereira, B. A., Lawrence, M. G., Ma, X., Rebello, R. J., Chan, H., Niranjan, B., Wu, Y., Ellem, S., Guan, X., et al. (2019) · Molecular & Cellular Proteomics

Prostate Cancer Treatment and ResearchProtease and Inhibitor Mechanisms

Cited by 107

When two’s a crowd - Structural mapping of PEAK pseudokinase interactions identifies 14 3 3 as a molecular switch for PEAK3/Crk signaling.

Lucet, I., Roy, M., Surudoi, M., Kropp, A., Hou, J., Dai, W., Hardy, J., Liang, L.-Y., Cotton, T., Lechtenberg, B., et al. (2022) · Nature Communications

14-3-3 protein interactionsProtein Kinase Regulation and GTPase Signaling

Cited by 16

Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer

Yang, X., Ma, X., Zhao, T., Croucher, D. R., Nguyen, E. V., Clark, K. C., Hu, C., Latham, S. L., Bayly-Jones, C., Nguyen, B. V., et al. (2025) · Nature Communications

Protein Kinase Regulation and GTPase SignalingCancer Mechanisms and Therapy

Cited by 9

Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically ‘actionable’ signalling axis in triple negative breast cancer

Yang, X., Ma, X., Zhao, T., Croucher, D. R., Nguyen, E. V., Clark, K. C., Hu, C., Latham, S. L., Bayly-Jones, C., Nguyen, V. C. B., et al. (2024) · Nature Communications

Protein Kinase Regulation and GTPase SignalingCancer Mechanisms and Therapy

Cited by 9